Different ancillary immunodiagnostic assessments had been traditionally-established for diagnosis of bovine tuberculosis (BTB) both mobile or humoral as tuberculin pores and skin check (TST), gamma interferon (INF-γ), and oblique enzyme-linked immunosorbent assay (iELISA). These assessments had been consumed extra time and costly, and wanted subtle tools. To dissolve these issues, serological diagnosis relying on humoral immunity is the purpose of this work. Herein, slide-based agglutination check was chosen as a speedy and easy area check primarily based on purified protein by-product (PPD) antigen as well as to some supplementation supplies comparable to Staphylococcal protein A (SPA) and Streptococcal protein G (SPG) to enhance detection of BTB antibody in serum samples.
Gold nanoparticles (Au NPs) had been synthesized by gamma ray, and after full characterization, the synthesized Au NPs had been spherical, small-sized, and secure with none impurities. Addition of such supplementation reagents for serodiagnosis of tuberculosis is of paramount essential for the detection of serum antibodies in opposition to tuberculosis (TB) and it was thought of an simply easy and doable manner for enhancing TB diagnosis. TST gives the highest sensitivity (83.6%) amongst the different immunoassays, whereas the lowest specificity was recorded in TST (57.4%). SPA/SPG gives the finest efficiency in time period of mixed sensitivity and specificity (efficiency index) of 175.4.
The stage of IgG antibodies (Ab) to the measles virus in the blood serum was studied by ELISA using a typical set of reagents for the quantitative willpower of IgG by «VECTOR-BEST». In this work, 70 animals examined optimistic for TST in addition to 20 animals examined adverse for TST had been used for the diagnosis of BTB relying on humoral immune response primarily based on PPD slide agglutination check using reporter regents (SPA and/or SPG) both native or recombinant. The agglutination density was recorded and learn in Four levels of positivity with scores starting from adverse (-) to very sturdy response (++++) occurred in numerous occasions of agglutination.
Groups confirmed 100% optimistic reactivates employed in Exp. 1, 2, and 3 with differentiation of slide agglutination check density and was rated from reasonable positivity (2+) to very sturdy (4+), with predominant positivity in density of (3+). Pink-colored depth is related with the strengthened reactions between PPD-conjugated Au NPs and serum antibody of every examined samples, which permits for visible speedy, easy, and efficient engaging diagnosis of BTB. The specificity and sensitivity of the serological assessments had been characterised.
Therefore, the growth and makes use of of detection reagent (comparable to SPA and/or SPG) slide co-agglutination check (COAT), both native or recombinant (rSPA/SPG) for the detection of TB antibodies primarily based on PPD antigen, in addition to the makes use of of Au NPs rSPA/SPG as detection conjugate primarily based on the similar antigen, had been additionally carried out as a easy, speedy, delicate, particular, eco-friendly, and low value, which reveals an excellent potential in area and lab diagnosis of BTB. So, excessive discount in reagents that yields reactions equally as conventional strategies was wanted.
[Intensity of the immunity against measles in employees of the maternity unit in Moscow]
Measles stays an pressing drawback in Russian healthcare. Despite the ongoing vaccination, there is a rise in the incidence of measles. Prevention of measles is especially essential in high-risk teams, in addition to amongst healthcare professionals to stop hospital-acquired outbreaks of an infection. The length of post-vaccination immunity throughout the elimination of measles has not been sufficiently studied, so usually individuals who have had measles in childhood or have 1-2 vaccinations in opposition to the illness lose their protecting antibodies with age in the absence of pure boosterization.Goals and aims. To research the depth of particular immunity to measles in workers of the maternity unit.The research concerned 271 workers of the maternity unit aged 21 to 93 years (262 serum samples).
The end result was thought of adverse if the focus of IgG to the measles virus in examined pattern was ≤ 0.18 IU/ml and optimistic – if > 0.18 IU/ml. Results. The quantity of seronegatives ranged from 0% to 30.8% in feminineworkers with its most at age of 31-35 years. The lowest proportion of seronegative and the highest proportion of seropositive ladieshad beennoticedamongst the aged, > 60 years. There is a marked tendency for a rise of the proportion of individuals with common Ab ranges with age and a lower of the proportion of individuals with low Ab ranges. The proportion of seronegative ladies amongst workers exceeded the really helpful stage, which makes it doable for an nosocomial outbreak when an an infection is launched. The authors suggest that serological testing for the depth of the immune response in opposition to measles must be included in the normal of the pre-vaccination screening for adults.
Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies
Serological assessments for COVID-19 have been instrumental in finding out the epidemiology of the illness. However, the efficiency of the at the moment obtainable assessments is suffering from the drawback of variability. We have developed a high-throughput serological check succesful of concurrently detecting complete immunoglobulins (Ig) and immunoglobulin G (IgG) in opposition to nucleocapsid protein (NP) and spike protein (SP) and report its efficiency in detecting COVID-19 in medical samples. We designed and readyreagents for measuring NP-IgG, NP-Total Ig, SP-IgG, and SP-Total Ig (using N-terminally truncated NP (ΔN-NP) or receptor-binding area (RBD) antigen) devoted automated chemiluminescent enzyme immunoassay analyzer AIA-CL1200.
) Recombinant Escherichia coli Colicin-E5 immunity protein in ColE9 (aa 1-83) |
|||
| VAng-Lsx02228-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1356 |
|
Description: Escherichia coli Colicin-E5 immunity protein in ColE9, recombinant protein. |
|||
) Recombinant Escherichia coli Colicin-Ia immunity Protein (aa 1-111) |
|||
| VAng-Lsx02230-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli Colicin-Ia immunity protein, recombinant protein. |
|||
) Recombinant Escherichia coli Colicin-Ia immunity Protein (aa 1-32) |
|||
| VAng-Lsx02231-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2938 |
|
Description: Escherichia coli Colicin-Ia immunity protein (aa 1-32), recombinant protein. |
|||
Recombinant Escherichia coli Colicin-Ia immunity Protein (aa 1-32) |
|||
| VAng-Lsx02231-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2223 |
|
Description: Escherichia coli Colicin-Ia immunity protein (aa 1-32), recombinant protein. |
|||
) Recombinant Escherichia coli Colicin-Ib immunity Protein (aa 1-115) |
|||
| VAng-Lsx02232-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli Colicin-Ib immunity protein, recombinant protein. |
|||
 (colicin E5)) Recombinant Escherichia coli lys Protein (aa 20-47) (colicin E5) |
|||
| VAng-Lsx02478-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2401 |
|
Description: Escherichia coli Lysis protein for colicin E5, recombinant protein. |
|||
Recombinant Escherichia coli lys Protein (aa 20-47) (colicin E5) |
|||
| VAng-Lsx02478-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1714 |
|
Description: Escherichia coli Lysis protein for colicin E5, recombinant protein. |
|||
Recombinant Escherichia coli lys Protein (aa 20-47) (colicin E5) |
|||
| VAng-Lsx02478-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1191 |
|
Description: Escherichia coli Lysis protein for colicin E5, recombinant protein. |
|||
 Recombinant human Innate immunity activator protein |
|||
| P1297 | FN Test | 100ug | Ask for price |
|
|||
|
Description: Recombinant protein for human Innate immunity activator protein |
|||
 Icariside E5 |
|||
| TBW01327 | ChemNorm | unit | Ask for price |
 Protein) Recombinant RPV E5 (aa 1-44) Protein |
|||
| VAng-Wyb3608-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2511 |
|
Description: Reindeer papillomavirus protein E5, recombinant protein. |
|||
Recombinant RPV E5 (aa 1-44) Protein |
|||
| VAng-Wyb3608-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1783 |
|
Description: Reindeer papillomavirus protein E5, recombinant protein. |
|||
Recombinant RPV E5 (aa 1-44) Protein |
|||
| VAng-Wyb3608-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1246 |
|
Description: Reindeer papillomavirus protein E5, recombinant protein. |
|||
 Protein) Recombinant CRPV E5 (aa 1-101) Protein |
|||
| VAng-Wyb2940-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2840 |
|
Description: Cottontail rabbit papillomavirus Probable protein E5, recombinant protein. |
|||
Recombinant CRPV E5 (aa 1-101) Protein |
|||
| VAng-Wyb2940-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2044 |
|
Description: Cottontail rabbit papillomavirus Probable protein E5, recombinant protein. |
|||
Recombinant CRPV E5 (aa 1-101) Protein |
|||
| VAng-Wyb2940-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1411 |
|
Description: Cottontail rabbit papillomavirus Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant EEPV E5 (aa 1-43) Protein |
|||
| VAng-Wyb2957-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2498 |
|
Description: European elk papillomavirus Protein E5, recombinant protein. |
|||
Recombinant EEPV E5 (aa 1-43) Protein |
|||
| VAng-Wyb2957-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1783 |
|
Description: European elk papillomavirus Protein E5, recombinant protein. |
|||
Recombinant EEPV E5 (aa 1-43) Protein |
|||
| VAng-Wyb2957-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1246 |
|
Description: European elk papillomavirus Protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-6a E5 (aa 1-91) Protein |
|||
| VAng-Wyb3388-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2785 |
|
Description: Human papillomavirus type 6a Probable protein E5A, recombinant protein. |
|||
Recombinant HPV-6a E5 (aa 1-91) Protein |
|||
| VAng-Wyb3388-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2003 |
|
Description: Human papillomavirus type 6a Probable protein E5A, recombinant protein. |
|||
Recombinant HPV-6a E5 (aa 1-91) Protein |
|||
| VAng-Wyb3388-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1384 |
|
Description: Human papillomavirus type 6a Probable protein E5A, recombinant protein. |
|||
 Protein) Recombinant HPV-70 E5 (aa 1-78) Protein |
|||
| VAng-Wyb3412-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2718 |
|
Description: Human papillomavirus type 70 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-70 E5 (aa 1-78) Protein |
|||
| VAng-Wyb3412-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1934 |
|
Description: Human papillomavirus type 70 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-70 E5 (aa 1-78) Protein |
|||
| VAng-Wyb3412-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1343 |
|
Description: Human papillomavirus type 70 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant Rhpv-1 E5 (aa 1-157) Protein |
|||
| VAng-Wyb3604-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3198 |
|
Description: Rhesus papillomavirus type 1 Probable protein E5, recombinant protein. |
|||
Recombinant Rhpv-1 E5 (aa 1-157) Protein |
|||
| VAng-Wyb3604-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2291 |
|
Description: Rhesus papillomavirus type 1 Probable protein E5, recombinant protein. |
|||
Recombinant Rhpv-1 E5 (aa 1-157) Protein |
|||
| VAng-Wyb3604-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1576 |
|
Description: Rhesus papillomavirus type 1 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant BPV-1 E5 (aa 1-44) Protein |
|||
| VAng-Wyb2887-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2511 |
|
Description: Bovinepapillomavirus type 1 Protein E5, recombinant protein. |
|||
Recombinant BPV-1 E5 (aa 1-44) Protein |
|||
| VAng-Wyb2887-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1783 |
|
Description: Bovinepapillomavirus type 1 Protein E5, recombinant protein. |
|||
Recombinant BPV-1 E5 (aa 1-44) Protein |
|||
| VAng-Wyb2887-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1246 |
|
Description: Bovinepapillomavirus type 1 Protein E5, recombinant protein. |
|||
 Protein) Recombinant BPV-2 E5 (aa 1-44) Protein |
|||
| VAng-Wyb2896-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2511 |
|
Description: Bovinepapillomavirus type 2 protein E5, recombinant protein. |
|||
Recombinant BPV-2 E5 (aa 1-44) Protein |
|||
| VAng-Wyb2896-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1783 |
|
Description: Bovinepapillomavirus type 2 protein E5, recombinant protein. |
|||
Recombinant BPV-2 E5 (aa 1-44) Protein |
|||
| VAng-Wyb2896-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1246 |
|
Description: Bovinepapillomavirus type 2 protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-13 E5 (aa 1-91) Protein |
|||
| VAng-Wyb3022-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2785 |
|
Description: Human papillomavirus type 13 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-13 E5 (aa 1-91) Protein |
|||
| VAng-Wyb3022-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2003 |
|
Description: Human papillomavirus type 13 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-13 E5 (aa 1-91) Protein |
|||
| VAng-Wyb3022-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1384 |
|
Description: Human papillomavirus type 13 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-16 E5 (aa 1-83) Protein |
|||
| VAng-Wyb3036-100g | Creative Biolabs | 100 µg | EUR 5879 |
|
Description: Human papillomavirus type 16 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-16 E5 (aa 1-83) Protein |
|||
| VAng-Wyb3036-50g | Creative Biolabs | 50 µg | EUR 3335 |
|
Description: Human papillomavirus type 16 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-16 E5 (aa 30-41) Protein |
|||
| VAng-Wyb3037-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2305 |
|
Description: Human papillomavirus type 16 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-16 E5 (aa 30-41) Protein |
|||
| VAng-Wyb3037-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1645 |
|
Description: Human papillomavirus type 16 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-16 E5 (aa 30-41) Protein |
|||
| VAng-Wyb3037-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1150 |
|
Description: Human papillomavirus type 16 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-18 E5 (aa 1-73) Protein |
|||
| VAng-Wyb3057-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2690 |
|
Description: Human papillomavirus type 5 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-18 E5 (aa 1-73) Protein |
|||
| VAng-Wyb3057-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1920 |
|
Description: Human papillomavirus type 5 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-18 E5 (aa 1-73) Protein |
|||
| VAng-Wyb3057-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1329 |
|
Description: Human papillomavirus type 5 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-31 E5 (aa 1-84) Protein |
|||
| VAng-Wyb3165-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2759 |
|
Description: Human papillomavirus type 31 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-31 E5 (aa 1-84) Protein |
|||
| VAng-Wyb3165-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1961 |
|
Description: Human papillomavirus type 31 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-31 E5 (aa 1-84) Protein |
|||
| VAng-Wyb3165-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1356 |
|
Description: Human papillomavirus type 31 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-33 E5 (aa 1-75) Protein |
|||
| VAng-Wyb3179-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2704 |
|
Description: Human papillomavirus type 33 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-33 E5 (aa 1-75) Protein |
|||
| VAng-Wyb3179-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1934 |
|
Description: Human papillomavirus type 33 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-33 E5 (aa 1-75) Protein |
|||
| VAng-Wyb3179-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1329 |
|
Description: Human papillomavirus type 33 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-35 E5 (aa 1-81) Protein |
|||
| VAng-Wyb3193-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2745 |
|
Description: Human papillomavirus type 35 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-35 E5 (aa 1-81) Protein |
|||
| VAng-Wyb3193-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1948 |
|
Description: Human papillomavirus type 35 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-35 E5 (aa 1-81) Protein |
|||
| VAng-Wyb3193-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1343 |
|
Description: Human papillomavirus type 35 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-39 E5 (aa 1-72) Protein |
|||
| VAng-Wyb3218-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2690 |
|
Description: Human papillomavirus type 39 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-39 E5 (aa 1-72) Protein |
|||
| VAng-Wyb3218-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1906 |
|
Description: Human papillomavirus type 39 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-39 E5 (aa 1-72) Protein |
|||
| VAng-Wyb3218-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1315 |
|
Description: Human papillomavirus type 39 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-41 E5 (aa 1-78) Protein |
|||
| VAng-Wyb3232-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2718 |
|
Description: Human papillomavirus type 41 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-41 E5 (aa 1-78) Protein |
|||
| VAng-Wyb3232-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1934 |
|
Description: Human papillomavirus type 41 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-41 E5 (aa 1-78) Protein |
|||
| VAng-Wyb3232-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1343 |
|
Description: Human papillomavirus type 41 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-42 E5 (aa 1-95) Protein |
|||
| VAng-Wyb3240-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2814 |
|
Description: Human papillomavirus type 42 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-42 E5 (aa 1-95) Protein |
|||
| VAng-Wyb3240-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2016 |
|
Description: Human papillomavirus type 42 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-42 E5 (aa 1-95) Protein |
|||
| VAng-Wyb3240-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1384 |
|
Description: Human papillomavirus type 42 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-51 E5 (aa 1-84) Protein |
|||
| VAng-Wyb3293-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2759 |
|
Description: Human papillomavirus type 51 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-51 E5 (aa 1-84) Protein |
|||
| VAng-Wyb3293-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1961 |
|
Description: Human papillomavirus type 51 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-51 E5 (aa 1-84) Protein |
|||
| VAng-Wyb3293-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1356 |
|
Description: Human papillomavirus type 51 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-58 E5 (aa 1-76) Protein |
|||
| VAng-Wyb3336-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2718 |
|
Description: Human papillomavirus type 58 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-58 E5 (aa 1-76) Protein |
|||
| VAng-Wyb3336-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1934 |
|
Description: Human papillomavirus type 58 Probable protein E5, recombinant protein. |
|||
Recombinant HPV-58 E5 (aa 1-76) Protein |
|||
| VAng-Wyb3336-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1329 |
|
Description: Human papillomavirus type 58 Probable protein E5, recombinant protein. |
|||
 Protein) Recombinant HPV-5b E5 (aa 1-168) Protein |
|||
| VAng-Wyb3345-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3268 |
|
Description: Human papillomavirus type 5b Probable protein E5, recombinant protein. |
|||
Recombinant HPV-5b E5 (aa 1-168) Protein |
|||
| VAng-Wyb3345-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2346 |
|
Description: Human papillomavirus type 5b Probable protein E5, recombinant protein. |
|||
Recombinant HPV-5b E5 (aa 1-168) Protein |
|||
| VAng-Wyb3345-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1604 |
|
Description: Human papillomavirus type 5b Probable protein E5, recombinant protein. |
|||
 OsM3K-E5 Antibody |
|||
| abx018560-100ul | Abbexa | 100 ul | EUR 384 |
|
|||
 IRGM Immunity-Related GTPase Family, M Human Recombinant Protein |
|||
| PROTA1A4Y4 | BosterBio | Regular: 20ug | EUR 317 |
|
Description: IRGM Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 180 amino acids (23-181) and having a molecular mass of 20.1 kDa. IRGM is fused to a 21 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
) Recombinant Escherichia coli Colicin-E6 Protein (aa 1-551) |
|||
| VAng-Lsx02229-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5687 |
|
Description: Escherichia coli Colicin-E6, recombinant protein. |
|||
Recombinant Escherichia coli Colicin-E6 Protein (aa 1-551) |
|||
| VAng-Lsx02229-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4023 |
|
Description: Escherichia coli Colicin-E6, recombinant protein. |
|||
Recombinant Escherichia coli Colicin-E6 Protein (aa 1-551) |
|||
| VAng-Lsx02229-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2730 |
|
Description: Escherichia coli Colicin-E6, recombinant protein. |
|||
 mpt64L Protein |
|||
| E5-00061 | EnoGene | 1mg | EUR 960 |
 human colicin ELISA Kit |
|||
| 201-12-1747 | SunredBio | 96 tests | EUR 440 |
|
|||
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
 Human Colicin ELISA kit |
|||
| E01C0786-192T | B-Gene | 192 tests | EUR 1270 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Human Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Colicin ELISA kit |
|||
| E01C0786-48 | B-Gene | 1 plate of 48 wells | EUR 520 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Human Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Colicin ELISA kit |
|||
| E01C0786-96 | B-Gene | 1 plate of 96 wells | EUR 685 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Human Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Goat Colicin ELISA kit |
|||
| E06C0786-192T | B-Gene | 192 tests | EUR 1270 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Goat Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Colicin ELISA kit |
|||
| E06C0786-48 | B-Gene | 1 plate of 48 wells | EUR 520 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Goat Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Colicin ELISA kit |
|||
| E06C0786-96 | B-Gene | 1 plate of 96 wells | EUR 685 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Goat Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Mouse Colicin ELISA kit |
|||
| E03C0786-192T | B-Gene | 192 tests | EUR 1270 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Mouse Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Colicin ELISA kit |
|||
| E03C0786-48 | B-Gene | 1 plate of 48 wells | EUR 520 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Mouse Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Colicin ELISA kit |
|||
| E03C0786-96 | B-Gene | 1 plate of 96 wells | EUR 685 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Mouse Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Rabbit Colicin ELISA kit |
|||
| E04C0786-192T | B-Gene | 192 tests | EUR 1270 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Rabbit Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Colicin ELISA kit |
|||
| E04C0786-48 | B-Gene | 1 plate of 48 wells | EUR 520 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Rabbit Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Colicin ELISA kit |
|||
| E04C0786-96 | B-Gene | 1 plate of 96 wells | EUR 685 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Rabbit Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Rat Colicin ELISA kit |
|||
| E02C0786-192T | B-Gene | 192 tests | EUR 1270 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Rat Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Colicin ELISA kit |
|||
| E02C0786-48 | B-Gene | 1 plate of 48 wells | EUR 520 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Rat Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Colicin ELISA kit |
|||
| E02C0786-96 | B-Gene | 1 plate of 96 wells | EUR 685 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Rat Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
 Human Colicin ELISA Kit |
|||
| EHC0793 | Abclonal | 96Tests | EUR 521 |
 Monkey Colicin ELISA kit |
|||
| E09C0786-192T | B-Gene | 192 tests | EUR 1270 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Monkey Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Colicin ELISA kit |
|||
| E09C0786-48 | B-Gene | 1 plate of 48 wells | EUR 520 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Monkey Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Colicin ELISA kit |
|||
| E09C0786-96 | B-Gene | 1 plate of 96 wells | EUR 685 |
|
|||
|
Description: A competitive ELISA for quantitative measurement of Monkey Colicin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
After figuring out the basal thresholds primarily based on 17 sera obtained from confirmed COVID-19 sufferers and 600 adverse sera, the medical validity of the assay was evaluated using impartial 202 optimistic samples and 1,000 adverse samples from wholesome donors. All of the 4 check parameters confirmed 100% specificity individually (1,000/1,000; 95%CI, 99.63-100). The sensitivity of the assay elevated proportionally to the elapsed time from signs onset, and all the assessments achieved 100% sensitivity (153/153; 95%CI, 97.63-100) after 13 days from signs onset. NP-Total Ig was the earliest to attain maximal sensitivity amongst the different antibodies examined.